The Healthcare Specialist
Driven by Passion.
Powered by Science.
Passion is our driver and science is our foundation. At Rhenman & Partners we only invest in the healthcare sector and our investment process takes both scientific and financial aspects into consideration. The portfolio managers specialize in different parts of the healthcare sector. They are supported in their investment decisions through close collaboration with our Scientific Advisory Board, which consists of eminent experts within different medical fields. The members of the Scientific Advisory Board, in turn, have their own wide networks of researchers and specialists around the world. Together, this enables us to make investment decisions based on solid, scientific information.
Rhenman Healthcare Equity L/S is an AIF which is available to retail investors in Sweden and Finland only, and it is registered for professional investors only in Belgium, Finland, the Netherlands, Italy, Sweden, the United Kingdom, Singapore with restricted scheme offered to accredited investors only and Switzerland (distributed without FINMA registration.
*As of XX-XX-XXXX (IC1 EUR)
Rhenman Healthcare Equity L/S (RHE L/S)
| FUND CLASS | NAV | DEVELOPMENT 1 MONTH | THIS YEAR | SINCE FUND START | START DATE |
| IC1 (EUR) | 824.26 | -4.79% | -10.07% | 724.26% | 22/06/2009 |
| IC3 (EUR) | 1065.35 | -4.73% | -9.85% | 965.35% | 31/07/2009 |
| IC2 (SEK) | 656.75 | -3.72% | -13.69% | 556.75% | 31/12/2012 |
| ID1 (SEK) Distributing | 359.05 | -3.76% | -17.57% | 259.05% | 30/04/2012 |
| IC1 (USD) | 211.68 | 0.22% | -1.29% | 111.68% | 31/01/2015 |
| RC1 (EUR) | 700.21 | -4.83% | -10.23% | 600.21% | 31/08/2010 |
| RC1 (SEK) | 753.46 | -3.80% | -13.98% | 653.46% | 22/06/2009 |
| RC2 (SEK) | 807.13 | -3.76% | -13.84% | 707.13% | 22/06/2009 |
Important information: Past performance is no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that investors will get back the entire invested capital.
Rhenman Healthcare Equity L/S
Important information: Past performance is no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that investors will get back the entire invested capital.
This is Rhenman & Partners
Who we are
A team of healthcare specialists
One of the most important success factors is our team of passionately engaged portfolio managers, each one with a specific focus within the sub-sectors: pharmaceuticals, biotech, medical technology, and healthcare services.
In addition to their own deep knowledge within their niche, they have constant access to our Scientific Advisory Board which means they are able to identify trends, innovations, and companies with high potential at an early stage.
The science behind
our portfolio managers.
One of the keys to the fund’s success is that investment decisions are based on solid scientific and financial information. Our portfolio managers do not only have deep specialist knowledge within their respective fields. They also collaborate closely with our Scientific Advisory Board, which consists of eminent medical experts, each with their owna broad network of medical researchers and specialists around the world. This collaborative process provides invaluable insights for our investment decisions and enables us to take a higher, yet more balanced level of risk.
Our unique scientific
working method.
Our way of working is built upon a well-tried, quality-assured investment strategy, and the close collaboration between the portfolio managers and our Scientific Advisory Board.
Portfolio managers with expert knowledge
Our portfolio managers have a deep level of expert competence within the sub-sectors: pharmaceuticals, biotech, medical technology and healthcare services.
Backed by the Scientific Advisory Board
The portfolio managers regularly present and discuss their analyses with the Scientific Advisory Board.
A mandate to take on risk
Thanks to our scientific method, our in-depth analysis, and our more flexible investment mandate, we are able to take on a higher, yet more balanced level of risk.
A sector with potential
The healthcare sector is characterized by research and innovation and is driven by megatrends, such as, population growth, higher living standards and digitalization.
Responsible investments
Together, we make the world a little healthier
By investing in healthcare, innovations within medical research receive support which in turn helps make the world a little healthier and improves people’s quality of life.
News
All
Direkt
Finwire
Uncategorized
Rhenman & Partners
Subscribe to ‘News’
Read interesting news, the portfolio managers’ insights and the latest developments in the fund.